GlassScriptPhysician profile
Sujata Wagh
NPI 1750444279
$6,932.36
in general payments reported to CMS, 2019-2025
50 companies · $2,727 in 2025
The $2,727 reported for 2025 was more than what 82% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $161 · 2021: $399 · 2022: $886 · 2023: $1,092 · 2024: $1,098 · 2025: $2,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,916.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $652.46 | 2020-2025 | Omnipod |
| Abbott Laboratories | $496.00 | 2021-2025 | Freestyle Libre 3, Eterna |
| Novo Nordisk INC | $446.84 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $394.77 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $340.58 | 2020-2025 | Synthroid |
| Corcept Therapeutics | $334.25 | 2023-2025 | Korlym |
| Dexcom, INC. | $294.93 | 2020-2025 | Dexcom G6 Transmitter |
| Conmed Corporation | $254.13 | 2019 | |
| Amneal Pharmaceuticals LLC | $253.40 | 2022-2025 | Unithroid |
| Cequr Corporation | $244.38 | 2023-2025 | Cequr Simplicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.70 | 2022-2025 | Synjardy, Jardiance, Trijardy Xr |
| Antares Pharma, INC. | $199.43 | 2021-2025 | Xyosted |
| Radius Health, INC. | $193.34 | 2022-2025 | Tymlos |
| Neurocrine Biosciences, INC. | $187.74 | 2025 | |
| Amgen INC. | $164.24 | 2019-2025 | Evenity, Prolia, Repatha |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $161.40 | 2025 | Yorvipath |
| Bayer Healthcare Pharmaceuticals INC. | $160.63 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $157.32 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $131.45 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Beta Bionics, INC. | $130.62 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Amphastar Pharmaceuticals, INC. | $117.71 | 2024 | Baqsimi |
| Mannkind Corporation | $116.28 | 2020-2023 | Afrezza |
| Astrazeneca Pharmaceuticals LP | $109.35 | 2021-2022 | |
| Medtronic Minimed, INC. | $109.32 | 2019-2020 | |
| Medtronic, INC. | $97.89 | 2021-2024 | Minimed 780g |
| Currax Pharmaceuticals LLC | $87.05 | 2023-2024 | Contrave, Nexletol, Nexlizet |
| Pfizer INC. | $84.85 | 2021-2024 | |
| Ibsa Pharma INC. | $71.55 | 2019-2023 | Tirosint, Licart |
| Recordati_rare_diseases_inc. | $71.37 | 2023-2024 | Isturisa, Signifor Lar |
| Ionis Pharmaceuticals, INC. | $61.68 | 2025 | Tryngolza |
| Amryt Pharma Holdings LTD | $54.54 | 2022-2023 | Mycapssa |
| Lifescan, INC. | $49.30 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $42.97 | 2023-2024 | Strensiq |
| Janssen Pharmaceuticals, INC | $33.74 | 2019-2020 | |
| Chiesi USA, INC. | $33.72 | 2025 | Mycapssa |
| Ultragenyx Pharmaceutical INC. | $33.67 | 2022 | |
| Vistapharm, INC. | $31.66 | 2021 | |
| Zealand Pharma US, INC. | $31.31 | 2021 | |
| Teleflex LLC | $30.84 | 2023-2024 | Titan Sgs Standard Gastric Stapler, Weck |
| Tandem Diabetes Care, INC. | $30.75 | 2022 | |
| Sequel Med Tech, LLC | $30.58 | 2025 | Twiist |
| Astellas Pharma US INC | $29.07 | 2024 | Veozah |
| Globus Medical, INC. | $25.57 | 2025 | Senza |
| Madrigal Pharmaceuticals | $22.31 | 2025 | Rezdiffra |
| Grt US Holding, INC. | $21.48 | 2021 | |
| Horizon Therapeutics Plc | $19.33 | 2022 | |
| Kyowa Kirin, INC. | $18.88 | 2025 | |
| Standard Bariatrics, INC. | $17.08 | 2022 | |
| Senseonics, Incorporated | $14.00 | 2019 | |
| Acerus Pharmaceuticals Corporation | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujata Wagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.